Marshall Wace, LLP Accolade, Inc. Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Accolade, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 77,484 shares of ACCD stock, worth $277,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,484

Holding current value

$277,392

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.22 - $15.02 $714,402 - $1.16 Million	77,484 New	77,484 $812,000
Q2 2023 Aug 14, 2023	BUY	$10.52 - $16.06 $3.97 Million - $6.06 Million	377,565 New	377,565 $5.09 Million
Q3 2022 Nov 14, 2022	BUY	$0.0 - $12.8 $0 - $350,835	27,409 Added 138.6%	47,184 $539,000
Q2 2022 Aug 15, 2022	BUY	$5.28 - $18.9 $104,412 - $373,747	19,775 New	19,775 $146,000
Q1 2022 May 16, 2022	SELL	$12.92 - $27.18 $6.19 Million - $13 Million	-479,378 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$21.96 - $42.69 $9.55 Million - $18.6 Million	434,898 Added 977.74%	479,378 $12.6 Million
Q3 2021 Nov 15, 2021	BUY	$41.3 - $54.56 $1.84 Million - $2.43 Million	44,480 New	44,480 $1.88 Million
Q1 2021 May 17, 2021	SELL	$38.1 - $59.09 $376,389 - $583,750	-9,879 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.26 - $59.72 $328,575 - $589,973	9,879 New	9,879 $430,000

Others Institutions Holding ACCD

# of Institutions

171

Shares Held

68.5M

Call Options Held

163K

Put Options Held

492K

Brown Advisory Inc

5.85M
Shares

$20.9 Million
0.08% of portfolio
Black Rock Inc. New York, NY

5.66M
Shares

$20.3 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

5.61M
Shares

$20.1 Million
0.42% of portfolio
Vanguard Group Inc Valley Forge, PA

5.4M
Shares

$19.3 Million
0.0% of portfolio
Jpmorgan Chase & CO New York, NY

5.33M
Shares

$19.1 Million
0.01% of portfolio

View Full List

About Accolade, Inc.

Ticker ACCD
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 71,938,896
Market Cap $258M
Description
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...

More about ACCD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account